Hemoglobin Evanston (alpha 14 Trp----Arg). An unstable alpha-chain variant expressed as alpha-thalassemia. 1984

G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis

A new hematologic syndrome with phenotypic features of mild Hb H disease was identified in three children from two unrelated black American families. Erythrocytes from each of these children contained Hb H (beta 4) and Hb Barts (gamma 4), as well as a slowly migrating hemoglobin fraction that made up 7-10% of the total hemoglobin. The parents of the affected children all showed mild thalassemia-like changes, with one of the parents in each family also expressing the variant hemoglobin; in the latter individuals the mutant alpha-chains made up less than 2% of the total, and were present mainly or exclusively in combination with delta-chains in the form of a slowly migrating Hb A2. Purified Hb Evanston showed an increased oxygen affinity, but its Bohr effect, cooperativity, and 2,3-diphosphoglycerate effect were normal. The mutant hemoglobin appeared to have normal stability to heat and to isopropanol, and the stability of its alpha-chain in an extended time course synthesis study also appeared to be similar to that of alpha A. However, the results from short-term globin synthesis studies, and from mRNA translation in vitro, suggest that the two types of alpha-chains were synthesized at relatively equal rates, with a major fraction of the newly synthesized variant alpha-chains undergoing rapid catabolism. The hematologic data taken in combination with DNA hybridization and globin synthesis findings indicate that the proposita in each of these families has the genotype--, alpha A/--, alpha Ev. These observations suggest that two separate mechanisms are contributing to the alpha-thalassemia-like expression of Hb Evanston : the newly synthesized alpha EV-chains are unstable and are subject to early proteolytic destruction; and the mutant alpha-allele is linked to an alpha-globin gene deletion.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic

Related Publications

G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
September 1983, Biochimica et biophysica acta,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 1979, Hemoglobin,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 2004, Hemoglobin,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 1987, Hemoglobin,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 1988, Hemoglobin,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 1974, Humangenetik,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
April 1984, FEBS letters,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
May 1979, The Journal of clinical investigation,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
January 1968, Biochimica et biophysica acta,
G R Honig, and M Shamsuddin, and L N Vida, and M Mompoint, and E Valcourt, and L J Bowie, and E C Jones, and P A Powers, and R A Spritz, and M Guis
February 2004, Hemoglobin,
Copied contents to your clipboard!